Skip to main content
. 2021 Dec 29;11(1):80. doi: 10.3390/antiox11010080

Figure 3.

Figure 3

Indicaxanthin treatment improves glucose dysmetabolism in HFD mice. Fasting glycaemia (A), glucose tolerance test (GTT) (B), area under the curve (AUC) for GTT (C), insulin tolerance test (ITT) (D), area under the curve for ITT (E), plasma insulin levels (F), HOMA index (G), protein expression levels of insulin receptor and actin in visceral adipose tissue (H) and densitometric quantification (I). Results are shown as means ± SEM of 8 animals/group. ns: p > 0.05; * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001 (ANOVA associated with Bonferroni’s correction).